Oculis Holding AG (OCS) Operating Leases (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Operating Leases came in at $2.3 million in Q1 2026, up 163.25% year-on-year from $888688.2 in Q1 2025, and up 3.25% quarter-over-quarter from $2.3 million in Q4 2025.

Oculis Holding AG (OCS) Operating Leases (2021 - 2026) Analysis & Trends

Oculis Holding AG's Operating Leases history runs 6 years deep, the most recent figure standing at $2.3 million for Q1 2026.

  • On a quarterly basis, Operating Leases rose 163.25% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 163.25% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 122.15% from the prior year.
  • Operating Leases rose to $2.3 million in Q1 2026 per OCS's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $2.6 million in Q3 2025 and bottomed at $470875.4 in Q1 2024.
  • The 5-year median for Operating Leases is $888688.2 (2025), against an average of $1.2 million.
  • Across the five-year window, Operating Leases decreased 22.21% in 2025 and soared 163.25% in 2026, its largest moves.
  • Year by year, Operating Leases stood at $657067.9 in 2022, then increased by 3.8% to $682049.5 in 2023, then surged by 44.77% to $987416.4 in 2024, then surged by 129.47% to $2.3 million in 2025, then advanced by 3.25% to $2.3 million in 2026.
  • Per Business Quant, the three latest OCS Operating Leases figures stand at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.34 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 869,680.96
Mar 31, 2025 888,688.18
Dec 31, 2024 987,416.40
Sep 30, 2024 1.07 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 470,875.43
Dec 31, 2023 682,049.46
Sep 30, 2023 571,737.04
Jun 30, 2023 599,462.62
Dec 31, 2022 657,067.87
Dec 31, 2021 625,757.71